Wnt pathway is affected by endocrine therapy in breast carcinomas

Author： Joo Yong Kyun   Logullo Angela Flávia   Mattar André   Nonogaki Suely   Soares Fernando Augusto   Gebrim Luíz Henrique  

Publisher： Blackwell Publishing

ISSN： 1755-9294

Source： Basic and Applied Pathology, Vol.4, Iss.2, 2011-06, pp. : 38-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IGF Signaling Pathway as a Selective Target of Familial Breast Cancer Therapy

By  

Current Molecular Medicine, Vol. 8, Iss. 8, 2008-12 ,pp. : 727-740

Bentham Science Publishers

Access to resources Recommend Favorite

Longterm outcomes following adjuvant endocrine therapy in breast cancer patients with a positivetonegative change of hormone receptor status following neoadjuvant chemotherapy

By                

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 997-1002

Spandidos Publications

Access to resources Recommend Favorite

The Wnt/Beta-Catenin Pathway in Wilms Tumors and Prostate Cancers

By  

Current Molecular Medicine, Vol. 7, Iss. 5, 2007-08 ,pp. : 479-489

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Angiogenesis Therapy in Head and Neck Squamous Cell Carcinomas

By  

Current Angiogenesis, Vol. 1, Iss. 1, 2012-04 ,pp. : 26-38

Bentham Science Publishers

Access to resources Recommend Favorite

Eccrine ductal and acrosyringeal differentiation of the breast epithelium—a lesion associated with some metaplastic breast carcinomas

By Tot Tibor  

Virchows Archiv, Vol. 449, Iss. 5, 2006-11 ,pp. : 565-571

Springer Publishing Company

Access to resources Recommend Favorite